|Bid||0.00 x 900|
|Ask||0.00 x 1200|
|Day's range||22.59 - 23.24|
|52-week range||13.16 - 31.00|
|Beta (3Y monthly)||N/A|
|PE ratio (TTM)||N/A|
|Forward dividend & yield||N/A (N/A)|
|1y target est||35.50|
The big shareholder groups in Celcuity Inc. (NASDAQ:CELC) have power over the company. Insiders often own a large chunk of younger, smaller, companies while huge companies tend to have institutions Read More...
NEW YORK, Dec. 11, 2018 -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors,.
HTG Molecular Diagnostics, Inc. (HTGM) (HTG), a provider of instruments, reagents, and services for molecular profiling applications, today announced the appointment of Maureen T. Cronin, Ph.D., as the Company’s Chief Scientific Officer and Senior Vice President as of November 16, 2018. Dr. Cronin is a veteran biotechnology, translational science and diagnostic executive. “HTG is incredibly honored to have Maureen join our company as she brings extensive experience in developing high-value precision diagnostics,” said TJ Johnson, Chief Executive Officer of HTG.